Examinando por Autor "A. Maiques"

Seleccione resultados tecleando las primeras letras
Mostrando 1 - 1 de 1
  • Miniatura
    Ítem
    Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC for its Spanish acronym) on the 2012 European Cardiovascular Prevention Guidelines
    (Elsevier, 2016-04-16) M.A. Royo-Bordonada; J.M. Lobos Bejarano; F. Villar Alvarez; S. Sans; A. Pérez; J. Pedro-Botet; R.M. Moreno Carriles; A. Maiques; Lizcano Álvarez, Ángel; V. Lizarbe; A. Gil Núñez; F. Fornés Ubeda
    Based on the two main frameworks for evaluating scientific evidence (SEC andGRADE) European cardiovascular prevention guidelines recommend interventions across alllife stages using a combination of population-based and high-risk strategies with diet asthe cornerstone of prevention. The evaluation of cardiovascular risk (CVR) incorporates HDLlevels and psychosocial factors, a very high risk category, and the concept of age-risk. Theyalso recommend cognitive-behavioural methods (e.g., motivational interviewing, psychologicalinterventions) led by health professionals and with the participation of the patient’s family, tocounterbalance psychosocial stress and reduce CVR through the institution of positive habitssuch as a healthy diet, physical activity, smoking cessation, and adherence to treatment. Addi-tionally, public health interventions —– such as smoking ban in public areas or the elimination oftrans fatty acids from the food chain —– are also essential. Other innovations include abandoningantiplatelet therapy in primary prevention and the recommendation of maintaining blood pres-sure within the 130-139/80-85 mmHg range in diabetic patients and individuals with high CVR.Finally, due to the significant impact on patient progress and medical costs, special emphasis isgiven to the low therapeutic adherence levels observed. In sum, improving cardiovascular pre-vention requires a true partnership among the political class, public administrations, scientificand professional associations, health foundations, consumer associations, patients and theirfamilies. Such partnership would promote population-based and individual strategies by takingadvantage of the broad spectrum of scientific evidence available, from clinical trials to observa-tional studies and mathematical models to evaluate population-based interventions, includingcost-effectiveness analyses.